2007年11月
Plexin-B1 mutations in prostate cancer
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- 巻
- 104
- 号
- 48
- 開始ページ
- 19040
- 終了ページ
- 19045
- 記述言語
- 英語
- 掲載種別
- DOI
- 10.1073/pnas.0702544104
- 出版者・発行元
- NATL ACAD SCIENCES
Semaphorins are a large class of secreted or membrane-associated proteins that act as chemotactic cues for cell movement via their transmembrane receptors, plexins. We hypothesized that the function of the semaphorin signaling pathway in the control of cell migration could be harnessed by cancer cells during invasion and metastasis. We now report 13 somatic missense mutations in the cytoplasmic domain of the Plexin-B1 gene. Mutations were found in 89% (8 of 9) of prostate cancer bone metastases, in 41% (7 of 17) of lymph node metastases, and in 46% (41 of 89) of primary cancers. Forty percent of prostate cancers contained the same mutation. Overexpression of the Plexin-B1 protein was found in the majority of primary tumors. The mutations hinder Rac and R-Ras binding and R-RasGAP activity, resulting in an increase in cell motility, invasion, adhesion, and lamellipodia extension. These results identify a key role for Plexin-B1 and the semaphorin signaling pathway it mediates in prostate cancer.
- リンク情報
- ID情報
-
- DOI : 10.1073/pnas.0702544104
- ISSN : 0027-8424
- J-Global ID : 200902272617659435
- Web of Science ID : WOS:000251498700032